Take Care,Operational Review - India
Consolidated Financial Performance
Figures in INR mn, unless stated otherwise
Profit and Loss Statement (1,3)
Key Balance Sheet Items(1)
Particulars (INR mn)
Q3 FY24
9M FY24
Particulars
31st December 2023
Total Operating Revenue
12,036
37,423
Shareholder Equity
Consumption
2,442
8,004
26,899
Doctors Expenses
2,185
6,504
Total Borrowings
Employee (Excluding Doctors) Expenses
10,162
2,542
7,549
Other Admin Expenses
2,078
6,788
Lease Liability
1,717
Total Expenses
9,247
28,846
Other Income
179
Net Block + CWIP (2)
514
25,892
EBITDA
2,968
9,091
Goodwill
Depreciation and Amortization
632
1773
1,178
Finance Costs
251
689
Right to Use Assets
1,802
Share of (loss)/profit of equity accounted
investees
Net Receivables
4,777
PBT
2,086
Tax Expense
205
6,629
641
Current Investments
5,804
PAT
Total Comprehensive Income
1,881
1,870
5,988
6,082
Cash and Bank Balance
4,557
-
As on December 31st, 2023, the Total Borrowings less Cash, Bank Balance and Current Investments was (INR 251 mn) – Net Cash representing a net
debt to equity ratio of (0.01) (out of which, debt worth US$ 61 mn is foreign currency denominated)
(1) Figures might not equal the reported numbers due to rounding off
(2) Net Block includes non-cash government grant impact of INR 1,098 mn, non-cash financial lease impact of INR 630 mn and non-cash EPCG license impact of INR 132 mn
(3) As per the accounting treatment for leases per IND AS 116 effective 1st April 2019 which resulted in INR 136 mn increase in depreciation, INR 36 mn increase in finance cost resulting in increase of INR 5
mn in PAT for Q3 FY 24 on pre-IND AS 116 basis
11View entire presentation